Microvesicles: Ubiquitous contributors to infection and immunity

Journal of Leukocyte Biology

Volumn 97, Issue 2, 2015, Pages 237-245

  Lai, Frances W ^a   Lichty, Brian D ^a   Bowdish, Dawn M E ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Ectosome; Exosome; Host pathogen interactions; Intracellular communication; Shedding vesicle; Wound healing

Indexed keywords

MESSENGER RNA; MICRORNA; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM; CELL COMMUNICATION; EXOSOME; HOST RESISTANCE; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNITY; INFECTION; MEMBRANE MICROPARTICLE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROKARYOTIC CELL; REVIEW; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; WOUND HEALING; ANIMAL; BLOOD CLOTTING; IMMUNOLOGY; PATHOLOGY; SECRETORY VESICLE;

EUKARYOTA; PROKARYOTA;

ANIMALS; BLOOD COAGULATION; EXOSOMES; HUMANS; IMMUNE EVASION; SECRETORY VESICLES; VIRULENCE FACTORS; VIRUS DISEASES; WOUND HEALING;

EID: 84925345100     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3RU0513-292RR     Document Type: Review

References (95)

1. Bishop, D. G., Work, E. (1965) An extracellular glycolipid produced by Escherichia coli grown under lysine-limiting conditions. Biochem. J. 96, 567–576.
2. Chatterjee, S. N., Das, J. (1967) Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae. J. Gen. Microbiol. 49, 1–11.
3. Wolf, P., (1967) The nature and significance of platelet products in human plasma Br. J. Haematol. 13, 269–288.
4. Sandberg, H., Andersson, L. O., Höglund, S. (1982) Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets. Biochem. J. 203, 303–311.
5. Sandberg, H., Bode, A. P., Dombrose, F. A., Hoechli, M., Lentz, B. R. (1985) Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3. Thromb. Res. 39, 63–79.
6. Trams, E. G., Lauter, C. J., Salem, Jr., N., Heine, U. (1981) Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim. Biophys. Acta 645, 63–70.
7. Pan, B. T., Teng, K., Wu, C., Adam, M., Johnstone, R. M. (1985) Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell Biol. 101, 942–948.
8. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., Lötvall, J. O. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659.
9. Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M. L., Schmittgen, T. D., Nana-Sinkam, S. P., Jarjoura, D., Marsh, C. B. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3, e3694.
10. Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., Angevin, E., Amigorena, S., Zitvogel, L. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7, 297–303.
11. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., Amigorena, S. (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cellderived exosomes. Nat. Med. 4, 594–600.
12. André, F., Chaput, N., Schartz, N. E. C., Flament, C., Aubert, N., Bernard, J., Lemonnier, F., Raposo, G., Escudier, B., Hsu, D-H., Tursz, T., Amigorena, S., Angevin, E., Zitvogel, L. (2004) Exosomes as potent cellfree peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172, 2126–2136.
13. Mangeot, P. E., Dollet, S., Girard, M., Ciancia, C., Joly, S., Peschanski, M., Lotteau, V. (2011) Protein transfer into human cells by VSV-G-induced nanovesicles. Mol. Ther. 19, 1656–1666.
14. Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., Zhang, H. G. (2010) A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 18, 1606–1614.
15. Maguire, C. A., Balaj, L., Sivaraman, S., Crommentuijn, M. H., Ericsson, M., Mincheva-Nilsson, L., Baranov, V., Gianni, D., Tannous, B. A., Sena- Esteves, M., Breakefield, X. O., Skog, J. (2012) Microvesicle-associated AAV vector as a novel gene delivery system. Mol. Ther. 20, 960–971.
16. Chaput, N., Flament, C., Viaud, S., Taieb, J., Roux, S., Spatz, A., André, F., LePecq, J-B., Boussac, M., Garin, J., Amigorena, S., Théry, C., Zitvogel, L. (2006) Dendritic cell derived-exosomes: biology and clinical implementations. J. Leukoc. Biol. 80, 471–478.
17. Cho, J-A., Yeo, D. J., Son, H-Y., Kim, H-W., Jung, D-S., Ko, J-K., Koh, J. S., Kim, Y-N., Kim, C-W. (2005) Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int. J. Cancer 114, 613–622.
18. Hu, G., Drescher, K. M., Chen, X. M. (2012) Exosomal miRNAs: biological properties and therapeutic potential. Front. Genet. 3, 56.
19. Kooijmans, S. A., Vader, P., van Dommelen, S. M., van Solinge, W. W., Schiffelers, R. M. (2012) Exosome mimetics: a novel class of drug delivery systems. Int. J. Nanomedicine 7, 1525–1541.
20. Tan, A., De La Peña, H., Seifalian, A. M. (2010) The application of exosomes as a nanoscale cancer vaccine. Int. J. Nanomedicine 5, 889–900.
21. Van Dommelen, S. M., Vader, P., Lakhal, S., Kooijmans, S. A., van Solinge, W. W., Wood, M. J., Schiffelers, R. M. (2012) Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release 161, 635–644.
22. Viaud, S., Théry, C., Ploix, S., Tursz, T., Lapierre, V., Lantz, O., Zitvogel, L., Chaput, N. (2010) Dendritic cell-derived exosomes for cancer immunotherapy: what’s next? Cancer Res. 70, 1281–1285.
23. Holmgren, L., Szeles, A., Rajnavölgyi, E., Folkman, J., Klein, G., Ernberg, I., Falk, K. I. (1999) Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 93, 3956–3963.
24. Bergsmedh, A., Szeles, A., Henriksson, M., Bratt, A., Folkman, M. J., Spetz, A. L., Holmgren, L. (2001) Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc. Natl. Acad. Sci. USA 98, 6407–6411.
25. Bellone, M., Iezzi, G., Rovere, P., Galati, G., Ronchetti, A., Protti, M. P., Davoust, J., Rugarli, C., Manfredi, A. A. (1997) Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159, 5391–5399.
26. Cocca, B. A., Cline, A. M., Radic, M. Z. (2002) Blebs and apoptotic bodies are B cell autoantigens. J. Immunol. 169, 159–166.
27. Schiller, M., Bekeredjian-Ding, I., Heyder, P., Blank, N., Ho, A. D., Lorenz, H. M. (2008) Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ. 15, 183–191.
28. Golpon, H. A., Fadok, V. A., Taraseviciene-Stewart, L., Scerbavicius, R., Sauer, C., Welte, T., Henson, P. M., Voelkel, N. F. (2004) Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J. 18, 1716–1718.
29. Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., Hristov, M., Köppel, T., Jahantigh, M. N., Lutgens, E., Wang, S., Olson, E. N., Schober, A., Weber, C. (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, ra81.
30. Heijnen, H. F., Schiel, A. E., Fijnheer, R., Geuze, H. J., Sixma, J. J. (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791–3799.
31. Sinauridze, E. I., Kireev, D. A., Popenko, N. Y., Pichugin, A. V., Panteleev, M. A., Krymskaya, O. V., Ataullakhanov, F. I. (2007) Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb. Haemost. 97, 425–434.
32. Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Croce, K., Furie, B. C., Furie, B. (2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J. Exp. Med. 197, 1585–1598.
33. Gross, P. L., Furie, B. C., Merrill-Skoloff, G., Chou, J., Furie, B. (2005) Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J. Leukoc. Biol. 78, 1318–1326.
34. Del Conde, I., Shrimpton, C. N., Thiagarajan, P., López, J. A. (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106, 1604–1611.
35. Esser, J., Gehrmann, U., D’Alexandri, F. L., Hidalgo-Estevez, A. M., Wheelock, C. E., Scheynius, A., Gabrielsson, S., Radmark, O. (2010) Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration. J. Allergy Clin. Immunol. 126, 1032–1040, 1040.e1–4.
36. Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., Sun, F., Lu, J., Yin, Y., Cai, X., Sun, Q., Wang, K., Ba, Y., Wang, Q., Wang, D., Yang, J., Liu, P., Xu, T., Yan, Q., Zhang, J., Zen, K., Zhang, C. Y. (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39, 133–144.
37. Huang, L., Zhao, A., Wong, F., Ayala, J. M., Struthers, M., Ujjainwalla, F., Wright, S. D., Springer, M. S., Evans, J., Cui, J. (2004) Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler. Thromb. Vasc. Biol. 24, 1783–1788.
38. Lärfars, G., Lantoine, F., Devynck, M-A., Palmblad, J., Gyllenhammar, H. (1999) Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes. Blood 93, 1399–1405.
39. Rola-Pleszczynski, M., Lemaire, I. (1985) Leukotrienes augment interleukin 1 production by human monocytes. J. Immunol. 135, 3958–3961.
40. Rola-Pleszczynski, M., Stanková, J. (1992) Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood 80, 1004–1011.
41. Gasser, O., Schifferli, J. A. (2004) Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 104, 2543–2548.
42. Eken, C., Martin, P. J., Sadallah, S., Treves, S., Schaller, M., Schifferli, J. A. (2010) Ectosomes released by polymorphonuclear neutrophils induce a MerTK-dependent anti-inflammatory pathway in macrophages. J. Biol. Chem. 285, 39914–39921.
43. Dasgupta, S. K., Le, A., Chavakis, T., Rumbaut, R. E., Thiagarajan, P. (2012) Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation 125, 1664–1672.
44. Choi, E. Y., Chavakis, E., Czabanka, M. A., Langer, H. F., Fraemohs, L., Economopoulou, M., Kundu, R. K., Orlandi, A., Zheng, Y. Y., Prieto, D. A., Ballantyne, C. M., Constant, S. L., Aird, W. C., Papayannopoulou, T., Gahmberg, C. G., Udey, M. C., Vajkoczy, P., Quertermous, T., Dimmeler, S., Weber, C., Chavakis, T. (2008) Del-1, an endogenous leukocyteendothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322, 1101–1104.
45. Agouni, A., Mostefai, H. A., Porro, C., Carusio, N., Favre, J., Richard, V., Henrion, D., Martínez, M. C., Andriantsitohaina, R. (2007) Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release. FASEB J. 21, 2735–2741.
46. Martínez, M. C., Larbret, F., Zobairi, F., Coulombe, J., Debili, N., Vainchenker, W., Ruat, M., Freyssinet, J. M. (2006) Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens. Blood 108, 3012–3020.
47. Soleti, R., Benameur, T., Porro, C., Panaro, M. A., Andriantsitohaina, R., Martínez, M. C. (2009) Microparticles harboring sonic hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors. Carcinogenesis 30, 580–588.
48. Deregibus, M. C., Cantaluppi, V., Calogero, R., Lo Iacono, M., Tetta, C., Biancone, L., Bruno, S., Bussolati, B., Camussi, G. (2007) Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110, 2440–2448.
49. Flanagan, J., Middeldorp, J., Sculley, T. (2003) Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J. Gen. Virol. 84, 1871–1879.
50. Houali, K., Wang, X., Shimizu, Y., Djennaoui, D., Nicholls, J., Fiorini, S., Bouguermouh, A., Ooka, T. (2007) A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 13, 4993–5000.
51. Ceccarelli, S., Visco, V., Raffa, S., Wakisaka, N., Pagano, J. S., Torrisi, M. R. (2007) Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes. Int. J. Cancer 121, 1494–1506.
52. Wakisaka, N., Murono, S., Yoshizaki, T., Furukawa, M., Pagano, J. S. (2002) Epstein-Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res. 62, 6337–6344.
53. Meckes, Jr., D.G., Shair, K. H., Marquitz, A. R., Kung, C. P., Edwards, R.H., Raab-Traub, N. (2010) Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. USA 107, 20370–20375.
54. Lenassi, M., Cagney, G., Liao, M., Vaupotic, T., Bartholomeeusen, K., Cheng, Y., Krogan, N. J., Plemenitas, A., Peterlin, B. M. (2010) HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 11, 110–122.
55. Masciopinto, F., Giovani, C., Campagnoli, S., Galli-Stampino, L., Colombatto, P., Brunetto, M., Yen, T. S., Houghton, M., Pileri, P., Abrignani, S. (2004) Association of hepatitis C virus envelope proteins with exosomes. Eur. J. Immunol. 34, 2834–2842.
56. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R., Landau, N. R. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661–666.
57. Mack, M., Kleinschmidt, A., Brühl, H., Klier, C., Nelson, P. J., Cihak, J., Plachý, J., Stangassinger, M., Erfle, V., Schlöndorff, D. (2000) Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat. Med. 6, 769–775.
58. Rozmyslowicz, T., Majka, M., Kijowski, J., Murphy, S. L., Conover, D. O., Poncz, M., Ratajczak, J., Gaulton, G. N., Ratajczak, M. Z. (2003) Plateletand megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 17, 33–42.
59. Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., Geuze, H. J. (1996) B Lymphocytes secrete antigenpresenting vesicles. J. Exp. Med. 183, 1161–1172.
60. Segura, E., Guérin, C., Hogg, N., Amigorena, S., Théry, C. (2007) CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J. Immunol. 179, 1489–1496.
61. Obregon, C., Rothen-Rutishauser, B., Gitahi, S. K., Gehr, P., Nicod, L. P. (2006) Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. Am. J. Pathol. 169, 2127–2136.
62. Giri, P. K., Schorey, J. S. (2008) Exosomes derived from M. bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. PLoS ONE 3, e2461.
63. Théry, C., Duban, L., Segura, E., Véron, P., Lantz, O., Amigorena, S. (2002) Indirect activation of na¨ıve CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 3, 1156–1162.
64. Obregon, C., Rothen-Rutishauser, B., Gerber, P., Gehr, P., Nicod, L. P. (2009) Active uptake of dendritic cell-derived exovesicles by epithelial cells induces the release of inflammatory mediators through a TNFalpha- mediated pathway. Am. J. Pathol. 175, 696–705.
65. Kesimer, M., Scull, M., Brighton, B., DeMaria, G., Burns, K., O’Neal, W., Pickles, R. J., Sheehan, J. K. (2009) Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 23, 1858–1868.
66. Khatua, A. K., Taylor, H. E., Hildreth, J. E., Popik, W. (2009) Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J. Virol. 83, 512–521.
67. Lee, R. C., Feinbaum, R. L., Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854.
68. Gibbings, D. J., Ciaudo, C., Erhardt, M., Voinnet, O. (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 11, 1143–1149.
69. Mittelbrunn, M., Gutiérrez-Vázquez, C., Villarroya-Beltri, C., González, S., Sánchez-Cabo, F., González, M. A., Bernad, A., Sánchez-Madrid, F. (2011) Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282.
70. Montecalvo, A., Larregina, A. T., Shufesky, W. J., Stolz, D. B., Sullivan, M. L., Karlsson, J. M., Baty, C. J., Gibson, G. A., Erdos, G., Wang, Z., Milosevic, J., Tkacheva, O. A., Divito, S. J., Jordan, R., Lyons-Weiler, J., Watkins, S. C., Morelli, A. E. (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119, 756–766.
71. Neumann, J., Eis-Hübinger, A. M., Koch, N. (2003) Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J. Immunol. 171, 3075–3083.
72. Temme, S., Eis-Hübinger, A. M., McLellan, A. D., Koch, N. (2010) The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J. Immunol. 184, 236–243.
73. Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A., van Eijndhoven, M. A., Hopmans, E. S., Lindenberg, J. L., de Gruijl, T. D., Würdinger, T., Middeldorp, J. M. (2010) Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. USA 107, 6328–6333.
74. Lo, A. K. F., To, K. F., Lo, K. W., Lung, R. W. M., Hui, J. W. Y., Liao, G., Hayward, S. D. (2007) Modulation of LMP1 protein expression by EBVencoded microRNAs. Proc. Natl. Acad. Sci. USA 104, 16164–16169.
75. Xia, T., O’Hara, A., Araujo, I., Barreto, J., Carvalho, E., Sapucaia, J. B., Ramos, J. C., Luz, E., Pedroso, C., Manrique, M., Toomey, N. L., Brites, C., Dittmer, D. P., Harrington, Jr., W. J. (2008) EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 68, 1436–1442.
76. Morse, M. A., Garst, J., Osada, T., Khan, S., Hobeika, A., Clay, T. M., Valente, N., Shreeniwas, R., Sutton, M. A., Delcayre, A., Hsu, D. H., Le Pecq, J. B., Lyerly, H. K. (2005) A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med. 3, 9.
77. Toth, B., Nieuwland, R., Liebhardt, S., Ditsch, N., Steinig, K., Stieber, P., Rank, A., Göhring, P., Thaler, C. J., Friese, K., Bauerfeind, I. (2008) Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res. 28, 1107–1112.
78. Tolson, D. L., Latta, R. K., Patel, G. B., Sprott, G. D. (1996) Uptake of archaeobacterial liposomes and conventional liposomes by phagocytic cells. J. Liposome Res. 6, 755–776.
79. Andre, F., Schartz, N. E. C., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., Tursz, T., Amigorena, S., Raposo, G., Angevin, E., Zitvogel, L. (2002) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360, 295–305.
80. Théry, C., Regnault, A., Garin, J., Wolfers, J., Zitvogel, L., Ricciardi- Castagnoli, P., Raposo, G., Amigorena, S. (1999) Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc 73. J. Cell Biol. 147, 599–610.
81. Horstman, A. L., Kuehn, M. J. (2000) Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J. Biol. Chem. 275, 12489–12496.
82. Lee, E-Y., Bang, J. Y., Park, G. W., Choi, D-S., Kang, J. S., Kim, H-J., Park, K-S., Lee, J-O., Kim, Y-K., Kwon, K-H., Kim, K. P., Gho, Y. S. (2007) Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics 7, 3143–3153.
83. Lee, E. Y., Choi, D. Y., Kim, D. K., Kim, J. W., Park, J. O., Kim, S., Kim, S. H., Desiderio, D. M., Kim, Y. K., Kim, K. P., Gho, Y. S. (2009) Grampositive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics 9, 5425–5436.
84. Rivera, J., Cordero, R. J. B., Nakouzi, A. S., Frases, S., Nicola, A., Casadevall, A. (2010) Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc. Natl. Acad. Sci. USA 107, 19002–19007.
85. Kadurugamuwa, J. L., Beveridge, T. J. (1995) Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177, 3998–4008.
86. Bomberger, J. M., Maceachran, D. P., Coutermarsh, B. A., Ye, S., O’Toole, G. A., Stanton, B. A. (2009) Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 5, e1000382.
87. Fiocca, R., Necchi, V., Sommi, P., Ricci, V., Telford, J., Cover, T. L., Solcia, E. (1999) Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium. J. Pathol. 188, 220–226.
88. Keenan, J., Day, T., Neal, S., Cook, B., Perez-Perez, G., Allardyce, R., Bagshaw, P. (2000) A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol. Lett. 182, 259–264.
89. Bhatnagar, S., Shinagawa, K., Castellino, F. J., Schorey, J. S. (2007) Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 110, 3234–3244.
90. Bhatnagar, S., Schorey, J. S. (2007) Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J. Biol. Chem. 282, 25779–25789.
91. Segura, E., Nicco, C., Lombard, B., Véron, P., Raposo, G., Batteux, F., Amigorena, S., Théry, C. (2005) ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 106, 216–223.
92. Alaniz, R. C., Deatherage, B. L., Lara, J. C., Cookson, B. T. (2007) Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol. 179, 7692–7701.
93. Bomberger, J. M., Ye, S., Maceachran, D. P., Koeppen, K., Barnaby, R. L., O’Toole, G. A., Stanton, B. A. (2011) A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. PLoS Pathog. 7, e1001325.
94. Ciofu, O., Beveridge, T. J., Kadurugamuwa, J., Walther-Rasmussen, J., Høiby, N. (2000) Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45, 9–13.
95. Schaar, V., Nordström, T., Mörgelin, M., Riesbeck, K. (2011) Moraxella catarrhalis outer membrane vesicles carry b-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob. Agents Chemother. 55, 3845–3853.